查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1995497

RFID血液監測系統市場：按組件類型、技術、應用和最終用戶分類－2026-2032年全球市場預測

RFID Blood Monitoring System Market by Component Type, Technology, Application, End-User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計 RFID 血液監測系統市場在 2025 年的價值為 2.0424 億美元，在 2026 年成長至 2.3796 億美元，到 2032 年達到 5.3428 億美元，複合年成長率為 14.72%。

主要市場統計數據
基準年 2025 2.0424億美元
預計年份：2026年 2.3796億美元
預測年份 2032 5.3428億美元
複合年成長率 (%) 14.72%

這是一本關於RFID血液監測系統的權威指南。說明了技術整合如何重新定義臨床安全、可追溯性和檢查室操作。

RFID血液管理系統的應用正在改變臨床實踐，為血液生命週期的每個階段帶來自動化視覺化和可追溯性。醫院、血庫和診斷檢查室正日益將硬體、軟體和服務結合，以減少人為錯誤、縮短檢測結果報告時間並加強合規性。因此，臨床團隊可以更加專注於患者照護，而供應鏈和檢查室管理人員則可以獲得可靠的即時數據，從而支援決策和風險規避。

整合 RFID 的部署、互通性和以服務為中心的經營模式如何改變整個醫療保健系統的臨床工作流程、低溫運輸完整性和病人安全。

血液監測領域正從孤立的技術先導計畫轉向將RFID技術融入臨床和供應鏈工作流程的整合式企業解決方案。早期部署主要側重於標籤和基本追蹤，而目前的重點是端到端可視性、預測性維護和閉合迴路臨床檢驗，以防止數據差異並減少輸血相關錯誤。與實驗室資訊系統和電子健康記錄（EHR）的互通性至關重要，這促使供應商提供開放的API和符合標準的中間件，以實現無縫的資料交換。

評估 2025 年美國關稅變化對 RFID 血液監測解決方案的籌資策略、供應鏈韌性和生命週期成本管理的連鎖反應。

美國2025年實施的關稅調整的累積影響，正在為醫療保健機構和RFID血液監測系統供應商帶來新的採購趨勢。部分進口電子元件和成品的關稅上調，並推高了部分硬體和配件的到貨成本，迫使採購者重新評估其籌資策略。為此，採購團隊正在仔細審查總體擁有成本（TCO），不僅考慮初始部署成本，還考慮安裝、維護和軟體訂閱模式等因素。

將組件選擇、技術權衡、臨床應用和最終用戶概況與 RFID 系統的最佳部署路徑連結起來的精細化細分洞察。

細分市場層面的趨勢揭示了不同組件、技術、應用和最終用戶類別如何影響RFID血液監測系統的部署路徑和投資重點。相關人員根據組件類型將支出分配到硬體、服務和軟體。硬體投資主要集中在天線、中間件、讀寫器和標籤上，而服務則包括諮詢、部署、維護和支援以及託管服務。這種以組件為中心的觀點強調，透過將耐用的硬體和軟體智慧與服務主導的部署相結合，可以創造永續價值，從而確保互通性和合規性。

區域市場動態和基礎設施因素決定了全球醫療保健區域的採購重點、監管合規性和部署策略。

區域趨勢在確定RFID血液監測系統的優先順序、監管合規流程和部署模式方面起著決定性作用。在美洲，需求主要受大規模綜合醫療保健系統、強大的私人血庫網路以及強調可追溯性和病人安全的監管要求所驅動。該地區的採購決策週期往往傾向於那些能夠與現有實驗室資訊系統互通性，並提供全面服務合約以支援大規模部署的解決方案。

受硬體創新、中介軟體整合和服務主導差異化影響的競爭和策略企業趨勢，影響部署和長期支援。

RFID血液監測系統市場的競爭格局呈現出多元化的特點，包括專業設備製造商、中介軟體和軟體供應商、系統整合商以及服務供應商。主要企業在硬體可靠性、標籤和讀寫器在低溫運輸環境下的性能、基於軟體的分析和事件管理以及支援臨床部署的全面專業服務等方面展開競爭。硬體供應商與實驗室資訊系統（LIS）供應商之間的夥伴關係是關鍵的差異化因素，能夠實現更順暢的整合並更快地實現營運目標。

就技術、採購、管治和服務策略提出切實可行的建議，以加速在臨床環境中安全、永續部署 RFID 技術。

為了充分發揮RFID血液監測系統的潛力，產業領導企業應採取整合策略，將技術選擇、服務夥伴關係和管治架構結合。首先，採購標準應與臨床風險狀況相匹配，確保技術選擇（無論是主動式RFID還是被動式RFID）與輸血監測和批量庫存追蹤等應用的關鍵性直接相關。這種匹配可以減少過度配置，並確保投資能夠實際提高安全性和工作流程效率。

為了得出切實可行的建議，我們採用高度透明、以證據為基礎的調查方法，整合了初步訪談、技術分析和基於情境的供應鏈評估。

本分析的調查方法結合了定性和定量方法，確保了研究結果的穩健性和實用性。主要資訊是透過與採購經理、臨床實驗室主任、血站管理人員和技術供應商進行結構化訪談和討論獲得的，從而獲取了關於營運重點、技術限制和服務需求的第一手觀點。除這些主要研究外，還對技術規格、監管指南和案例研究進行了系統性回顧，這些案例研究記錄了已實施的解決方案和臨床結果。

總結和展望基於 RFID 的血液監測定位，將其視為一項成熟的功能，對於患者安全、營運彈性和符合標準的臨床實踐至關重要。

基於RFID的血液監測系統對於提升血庫、診斷檢查室和醫療機構的可追溯性、病人安全和運作效率至關重要。標籤和讀取器技術的進步、中介軟體的互通性以及服務主導的部署模式正在融合，從而實現臨床有效且運作可行的解決方案。儘管價格波動和供應鏈壓力使採購變得複雜，但也加速了供應商策略的調整，這些策略強調本地化、採購多元化和捆綁式服務，以維持業務連續性並控制成本。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 RFID血液監測系統市場：依組件類型分類

  • 硬體
    • 天線
    • 中介軟體
    • 領導者
    • 標籤
  • 服務
    • 諮詢服務
    • 實施服務
    • 維護和支援
    • 託管服務
  • 軟體

第9章：RFID血液監測系統市場：依技術分類

  • 主動式RFID技術
  • 被動式射頻識別技術

第10章：RFID血液監測系統市場：依應用領域分類

  • 血液樣本追蹤
  • 血液儲存監測
  • 輸血監測
  • 庫存管理
  • 患者識別

第11章 RFID血液監測系統市場：依最終用戶分類

  • 血庫
    • 私人血庫
    • 公共血庫
  • 診斷檢測實驗室
  • 醫療保健提供者
    • 門診手術中心
    • 診所
    • 醫院

第12章 RFID血液監測系統市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章 RFID血液監測系統市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 RFID血液監測系統市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章：美國RFID血液監測系統市場

第16章：中國RFID血液監測系統市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Alien Technology, LLC
  • Bagmo Pvt Ltd
  • Biolog-id
  • Cardinal Health, Inc.
  • GAO RFID Inc.
  • Kent Scientific Corporation
  • Mobile Aspects Inc.
  • SATO Vicinity Pty. Ltd.
  • Terso Solutions, Inc.
  • Zebra Technologies
Product Code: MRR-FB6C9E792DD8

The RFID Blood Monitoring System Market was valued at USD 204.24 million in 2025 and is projected to grow to USD 237.96 million in 2026, with a CAGR of 14.72%, reaching USD 534.28 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 204.24 million
Estimated Year [2026] USD 237.96 million
Forecast Year [2032] USD 534.28 million
CAGR (%) 14.72%

An authoritative orientation to RFID blood monitoring systems that explains how technology integration is redefining clinical safety, traceability, and laboratory operations

The adoption of RFID-enabled blood monitoring systems is reshaping clinical operations by bringing automated visibility and traceability to every stage of the blood lifecycle. Hospitals, blood banks, and diagnostic laboratories are increasingly combining hardware, software, and services to reduce manual errors, speed turnaround times, and strengthen regulatory compliance. As a result, clinical teams can focus more on patient care while supply chain and laboratory managers gain reliable, real-time data that supports decision-making and risk mitigation.

Across healthcare environments, RFID solutions are being integrated into workflows that span from sample collection through processing, storage and transfusion. Newer implementations place emphasis on interoperability with laboratory information systems and electronic health records, enabling closed-loop verification and audit-ready logs. In parallel, service providers are expanding consulting, implementation, and managed services to accelerate deployments and reduce the burden on internal IT and clinical engineering teams.

This section synthesizes the drivers behind adoption, including the need for improved safety, the regulatory emphasis on traceability, and operational pressures to reduce waste and prevent adverse events. It also highlights how converging advances in tag technology, reader capabilities, and software analytics are enabling more granular monitoring of blood products across their lifecycle. Ultimately, these developments are creating a foundation for resilient, data-driven transfusion services and inventory practices.

How integrated RFID deployment, interoperability, and service-centric commercial models are transforming clinical workflows, cold-chain integrity, and patient safety across healthcare systems

The landscape for blood monitoring has shifted from isolated technological pilots to integrated enterprise solutions that embed RFID across clinical and supply chain workflows. Early deployments focused primarily on tagging and basic tracking, but current initiatives emphasize end-to-end visibility, predictive maintenance, and closed-loop clinical verification to prevent mismatches and reduce transfusion-related errors. Interoperability with laboratory information systems and EHRs has become a prerequisite, driving vendors to offer open APIs and standards-aligned middleware that enable seamless data exchange.

Concurrently, the balance between passive and active RFID approaches is evolving as stakeholders weigh cost, read range, and environmental resilience. Passive RFID increasingly supports high-density inventory tracking and patient identification at point-of-care, while active solutions enable continuous environmental and cold-chain monitoring for temperature-sensitive blood products. Additionally, managed service models and cloud-enabled analytics are making advanced capabilities accessible to smaller blood banks and clinics that lack deep in-house IT resources.

These transformative shifts are catalyzing new operating models. Healthcare providers are reorganizing cross-functional teams to incorporate device orchestration, data governance, and clinical informatics. As a result, procurement and clinical leadership must now evaluate not only hardware and software features but also lifecycle services, integration readiness, and the vendor's ability to support regulatory audits and continuous improvement efforts. The net effect is a more holistic approach to patient safety and inventory resilience driven by data and systems integration.

Evaluating the ripple effects of 2025 United States tariff changes on procurement strategies, supply-chain resilience, and lifecycle cost management for RFID blood monitoring solutions

The cumulative effects of tariff changes implemented by the United States in 2025 have introduced new procurement dynamics for healthcare providers and suppliers of RFID blood monitoring systems. Increased duties on certain imported electronic components and finished devices elevated landed costs for some hardware and accessory items, prompting purchasers to re-evaluate sourcing strategies. In response, procurement teams intensified scrutiny of total cost of ownership, considering not just upfront acquisition but also installation, maintenance, and software subscription models.

Manufacturers and distributors adapted by shifting manufacturing footprints, negotiating alternative component sourcing, and accelerating localization where feasible. These supply-chain adjustments resulted in a blend of nearshoring and diversified supplier relationships designed to mitigate exposure to tariff-related pricing volatility. At the same time, some vendors absorbed a portion of incremental cost to maintain competitive pricing, while others emphasized bundled service offerings to preserve margin and provide predictable expenditure for customers.

Clinicians and operational leaders saw indirect impacts: extended lead times for certain reader models or specialized tags, intermittent component availability, and renegotiated service contracts. Consequently, healthcare organizations prioritized procurement flexibility, including phased rollouts and pilot-first approaches that reduce capital concentration. The tariff-driven environment also reinforced the importance of contractual protections, transparent cost escalation clauses, and supplier continuity plans to ensure clinical services and blood safety programs remain uninterrupted.

Nuanced segmentation insights that link component decisions, technology trade-offs, clinical applications, and end-user profiles to tailored implementation pathways for RFID systems

Segment-level dynamics reveal how different components, technologies, applications, and end-user categories shape adoption pathways and investment priorities for RFID blood monitoring systems. Based on component type, stakeholders allocate spending across hardware, services, and software; hardware investments center on antennas, middleware, readers, and tags while services encompass consulting, implementation, maintenance and support, and managed services. This component-centric view emphasizes that durable value arises from harmonizing durable hardware with software intelligence and service-led deployment to ensure interoperability and regulatory readiness.

Based on technology, decision criteria hinge on the trade-offs between active RFID technology and passive RFID technology. Active RFID provides continuous monitoring and extended read ranges well suited for environmental and cold-chain applications, whereas passive RFID delivers cost-efficient item-level tracking and patient identification at scale. Consequently, many organizations adopt a hybrid technology posture that aligns the monitoring modality to application criticality and operational constraints.

Based on application, deployments are prioritized for blood sample tracking, blood storage monitoring, blood transfusion monitoring, inventory management, and patient identification. Each application imposes distinct requirements for tag durability, read fidelity, and integration with clinical workflows, leading to differentiated solution architectures and implementation sequencing. Based on end-user, adoption and procurement cycles vary across blood banks, diagnostic laboratories, and healthcare providers; blood banks bifurcate into private and public entities with divergent funding and compliance drivers, while healthcare providers include ambulatory surgical centers, clinics, and hospitals that present a range of infrastructure maturity and clinical complexity. Taken together, these segmentation lenses demonstrate that vendors and buyers must tailor commercial propositions, integration plans, and service commitments to the nuanced needs of each segment to achieve measurable clinical and operational outcomes.

Regional market dynamics and infrastructure considerations that determine procurement priorities, regulatory alignment, and deployment strategies across global healthcare geographies

Regional dynamics play a decisive role in prioritization, regulatory pathways, and deployment models for RFID blood monitoring systems. In the Americas, demand is driven by a combination of large integrated healthcare systems, robust private blood bank networks, and regulatory expectations that emphasize traceability and patient safety. Procurement decision cycles in this region often favor solutions that demonstrate interoperability with existing lab information systems and that offer comprehensive service agreements to support large-scale rollouts.

Europe, Middle East & Africa exhibits a heterogeneous landscape where regulatory frameworks, procurement modalities, and healthcare infrastructure vary significantly. In several European markets, stringent data protection and medical device regulations shape integration requirements and data governance practices, while in parts of the Middle East and Africa, growth is concentrated in hub hospitals and national blood services where modernization initiatives prioritize cold-chain integrity and inventory resilience.

In Asia-Pacific, a mix of advanced tertiary hospitals and rapidly modernizing regional clinics creates demand for both high-end integrated solutions and cost-effective, scalable deployments. Local manufacturing and supplier ecosystems in certain Asia-Pacific countries also influence vendor strategies, encouraging partnerships and localized support models. Across all regions, success depends on aligning technical capabilities with regional regulatory considerations, local service ecosystems, and the financing models that healthcare organizations prefer.

Competitive and strategic company dynamics framed by hardware innovation, middleware integration, and service-led differentiation that influence adoption and long-term support

Competitive dynamics within the RFID blood monitoring systems landscape reflect a blend of specialized device manufacturers, middleware and software vendors, integrators, and service providers. Leading companies compete on the strength of hardware reliability, tag and reader performance in cold-chain environments, software analytics and event management, and the depth of professional services that support clinical adoption. Partnerships between hardware vendors and laboratory information system suppliers have become important differentiators, enabling smoother integrations and faster return on operational objectives.

Vendor strategies also vary by emphasis: some prioritize innovation in tag design, materials, and battery life to support long-duration cold-chain monitoring, while others invest heavily in middleware that translates raw reads into clinical workflows and audit trails. Service-oriented players focus on delivering managed offerings that reduce the burden on healthcare IT and clinical engineering, providing predictable support SLAs and lifecycle maintenance. As procurement teams evaluate suppliers, they increasingly weigh not only technical performance but also the vendor's capacity to support scale, regulatory auditability, and continuous improvement through software updates and professional services.

Practical, high-impact recommendations for technology, procurement, governance, and service strategies that accelerate safe and sustainable RFID adoption in clinical settings

To capitalize on the potential of RFID-enabled blood monitoring systems, industry leaders should pursue an integrated strategy that blends technology selection, service partnerships, and governance frameworks. First, align procurement criteria to clinical risk profiles so that technology choices-whether active or passive RFID-map directly to application criticality such as transfusion monitoring versus bulk inventory tracking. This alignment reduces over-specification and ensures that investments deliver measurable improvements in safety and workflow efficiency.

Second, prioritize interoperability and vendor openness to accelerate integration with laboratory information systems and electronic health records. Contractual commitments to API access, standards compliance, and vendor-provided integration templates can significantly shorten deployment timelines and reduce hidden integration costs. Third, institutionalize service arrangements that cover consulting, implementation, and ongoing maintenance; embedding managed services or hybrid support models can be especially valuable for smaller blood banks and clinics that lack deep in-house technical capacity.

Fourth, strengthen supply-chain resilience through diversified sourcing and contingency planning to mitigate tariff, lead-time, and component availability risks. Fifth, establish clear data governance policies that address patient privacy, auditability, and retention of traceability records to meet regulatory expectations. Finally, invest in change management and clinician engagement programs to ensure that workflows adapt to new verification steps and that staff understand the safety and efficiency benefits of RFID-enabled processes. Together, these actions will accelerate adoption while protecting clinical continuity and optimizing total cost over the lifecycle of deployments.

A transparent, evidence-first research methodology that integrates primary interviews, technical analysis, and scenario-based supply-chain assessments to inform practical recommendations

The research methodology underpinning this analysis combines qualitative and quantitative approaches to ensure robustness and practical relevance. Primary intelligence was drawn from structured interviews and consultations with procurement leaders, clinical laboratory directors, blood center managers, and technology suppliers to capture firsthand perspectives on operational priorities, technical constraints, and service needs. These primary engagements were supplemented by a systematic review of technical specifications, regulatory guidance, and case studies that document implemented solutions and clinical outcomes.

Analytical methods included comparative feature mapping of hardware and software capabilities, scenario-based assessment of technology fit across applications, and supply-chain stress testing to evaluate procurement resilience under tariff and component disruption scenarios. Cross-validation with vendor documentation and publicly available regulatory frameworks ensured that findings remain consistent with prevailing clinical and compliance expectations. Throughout the process, emphasis was placed on replicable methods, transparent assumptions, and an evidence-first approach to support actionable recommendations and procurement playbooks for stakeholders.

Synthesis and outlook that frames RFID-enabled blood monitoring as a maturing capability essential to patient safety, operational resilience, and standards-aligned clinical practice

RFID-enabled blood monitoring systems represent a pivotal capability for enhancing traceability, patient safety, and operational efficiency across blood banks, diagnostic laboratories, and healthcare providers. The convergence of improved tag and reader technologies, middleware interoperability, and service-led deployment models is enabling solutions that are both clinically impactful and operationally feasible. While tariff shifts and supply-chain pressures have introduced procurement complexities, they have also accelerated supplier strategies that emphasize localization, diversified sourcing, and bundled service offerings to preserve continuity and control costs.

Looking ahead, the successful programs will be those that integrate technology choice with governance, clinician engagement, and robust supplier relationships. By aligning RFID modalities to application criticality, prioritizing interoperability, and institutionalizing service-based support models, healthcare organizations can achieve measurable reductions in transfusion errors, improve inventory utilization, and create audit-ready traceability. These outcomes depend on disciplined procurement processes, ongoing operational measurement, and a commitment to iterative improvement that incorporates user feedback and clinical performance data. In sum, RFID for blood monitoring is transitioning from experimental deployments to mature, standards-oriented implementations that materially strengthen patient safety and supply-chain resilience.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. RFID Blood Monitoring System Market, by Component Type

  • 8.1. Hardware
    • 8.1.1. Antennas
    • 8.1.2. Middleware
    • 8.1.3. Readers
    • 8.1.4. Tags
  • 8.2. Services
    • 8.2.1. Consulting Services
    • 8.2.2. Implementation Services
    • 8.2.3. Maintenance and Support
    • 8.2.4. Managed Services
  • 8.3. Software

9. RFID Blood Monitoring System Market, by Technology

  • 9.1. Active RFID Technology
  • 9.2. Passive RFID Technology

10. RFID Blood Monitoring System Market, by Application

  • 10.1. Blood Sample Tracking
  • 10.2. Blood Storage Monitoring
  • 10.3. Blood Transfusion Monitoring
  • 10.4. Inventory Management
  • 10.5. Patient Identification

11. RFID Blood Monitoring System Market, by End-User

  • 11.1. Blood Banks
    • 11.1.1. Private Blood Banks
    • 11.1.2. Public Blood Banks
  • 11.2. Diagnostic Laboratories
  • 11.3. Healthcare Providers
    • 11.3.1. Ambulatory Surgical Centers
    • 11.3.2. Clinics
    • 11.3.3. Hospitals

12. RFID Blood Monitoring System Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. RFID Blood Monitoring System Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. RFID Blood Monitoring System Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States RFID Blood Monitoring System Market

16. China RFID Blood Monitoring System Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Alien Technology, LLC
  • 17.6. Bagmo Pvt Ltd
  • 17.7. Biolog-id
  • 17.8. Cardinal Health, Inc.
  • 17.9. GAO RFID Inc.
  • 17.10. Kent Scientific Corporation
  • 17.11. Mobile Aspects Inc.
  • 17.12. SATO Vicinity Pty. Ltd.
  • 17.13. Terso Solutions, Inc.
  • 17.14. Zebra Technologies

LIST OF FIGURES

  • FIGURE 1. GLOBAL RFID BLOOD MONITORING SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL RFID BLOOD MONITORING SYSTEM MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL RFID BLOOD MONITORING SYSTEM MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY COMPONENT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY END-USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES RFID BLOOD MONITORING SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA RFID BLOOD MONITORING SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL RFID BLOOD MONITORING SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY COMPONENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY HARDWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY HARDWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY HARDWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY ANTENNAS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY ANTENNAS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY ANTENNAS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY MIDDLEWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY MIDDLEWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY MIDDLEWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY READERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY READERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY READERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY TAGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY TAGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY TAGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY CONSULTING SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY CONSULTING SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY CONSULTING SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY IMPLEMENTATION SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY IMPLEMENTATION SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY IMPLEMENTATION SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY MAINTENANCE AND SUPPORT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY MAINTENANCE AND SUPPORT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY MAINTENANCE AND SUPPORT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY MANAGED SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY MANAGED SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY MANAGED SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY ACTIVE RFID TECHNOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY ACTIVE RFID TECHNOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY ACTIVE RFID TECHNOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY PASSIVE RFID TECHNOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY PASSIVE RFID TECHNOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY PASSIVE RFID TECHNOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY BLOOD SAMPLE TRACKING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY BLOOD SAMPLE TRACKING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY BLOOD SAMPLE TRACKING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY BLOOD STORAGE MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY BLOOD STORAGE MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY BLOOD STORAGE MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY BLOOD TRANSFUSION MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY BLOOD TRANSFUSION MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY BLOOD TRANSFUSION MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY INVENTORY MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY INVENTORY MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY INVENTORY MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY PATIENT IDENTIFICATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY PATIENT IDENTIFICATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY PATIENT IDENTIFICATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY BLOOD BANKS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY BLOOD BANKS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY BLOOD BANKS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY BLOOD BANKS, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY PRIVATE BLOOD BANKS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY PRIVATE BLOOD BANKS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY PRIVATE BLOOD BANKS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY PUBLIC BLOOD BANKS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY PUBLIC BLOOD BANKS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY PUBLIC BLOOD BANKS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY HEALTHCARE PROVIDERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY HEALTHCARE PROVIDERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY HEALTHCARE PROVIDERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. AMERICAS RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 90. AMERICAS RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY COMPONENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 91. AMERICAS RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 92. AMERICAS RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 93. AMERICAS RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 94. AMERICAS RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 95. AMERICAS RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 96. AMERICAS RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY BLOOD BANKS, 2018-2032 (USD MILLION)
  • TABLE 97. AMERICAS RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2032 (USD MILLION)
  • TABLE 98. NORTH AMERICA RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. NORTH AMERICA RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY COMPONENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 100. NORTH AMERICA RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 101. NORTH AMERICA RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 102. NORTH AMERICA RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 103. NORTH AMERICA RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 104. NORTH AMERICA RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 105. NORTH AMERICA RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY BLOOD BANKS, 2018-2032 (USD MILLION)
  • TABLE 106. NORTH AMERICA RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2032 (USD MILLION)
  • TABLE 107. LATIN AMERICA RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. LATIN AMERICA RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY COMPONENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 109. LATIN AMERICA RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 110. LATIN AMERICA RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 111. LATIN AMERICA RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 112. LATIN AMERICA RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 113. LATIN AMERICA RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 114. LATIN AMERICA RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY BLOOD BANKS, 2018-2032 (USD MILLION)
  • TABLE 115. LATIN AMERICA RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPE, MIDDLE EAST & AFRICA RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPE, MIDDLE EAST & AFRICA RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY COMPONENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE, MIDDLE EAST & AFRICA RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPE, MIDDLE EAST & AFRICA RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPE, MIDDLE EAST & AFRICA RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE, MIDDLE EAST & AFRICA RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPE, MIDDLE EAST & AFRICA RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY BLOOD BANKS, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY COMPONENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY BLOOD BANKS, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2032 (USD MILLION)
  • TABLE 134. MIDDLE EAST RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. MIDDLE EAST RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY COMPONENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 136. MIDDLE EAST RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 137. MIDDLE EAST RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 138. MIDDLE EAST RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 139. MIDDLE EAST RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 140. MIDDLE EAST RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 141. MIDDLE EAST RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY BLOOD BANKS, 2018-2032 (USD MILLION)
  • TABLE 142. MIDDLE EAST RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2032 (USD MILLION)
  • TABLE 143. AFRICA RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 144. AFRICA RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY COMPONENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 145. AFRICA RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 146. AFRICA RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 147. AFRICA RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 148. AFRICA RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 149. AFRICA RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 150. AFRICA RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY BLOOD BANKS, 2018-2032 (USD MILLION)
  • TABLE 151. AFRICA RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2032 (USD MILLION)
  • TABLE 152. ASIA-PACIFIC RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 153. ASIA-PACIFIC RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY COMPONENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 154. ASIA-PACIFIC RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 155. ASIA-PACIFIC RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 156. ASIA-PACIFIC RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 157. ASIA-PACIFIC RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 158. ASIA-PACIFIC RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 159. ASIA-PACIFIC RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY BLOOD BANKS, 2018-2032 (USD MILLION)
  • TABLE 160. ASIA-PACIFIC RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2032 (USD MILLION)
  • TABLE 161. GLOBAL RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 162. ASEAN RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 163. ASEAN RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY COMPONENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 164. ASEAN RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 165. ASEAN RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 166. ASEAN RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 167. ASEAN RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 168. ASEAN RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 169. ASEAN RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY BLOOD BANKS, 2018-2032 (USD MILLION)
  • TABLE 170. ASEAN RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2032 (USD MILLION)
  • TABLE 171. GCC RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 172. GCC RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY COMPONENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 173. GCC RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 174. GCC RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 175. GCC RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 176. GCC RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 177. GCC RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 178. GCC RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY BLOOD BANKS, 2018-2032 (USD MILLION)
  • TABLE 179. GCC RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPEAN UNION RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPEAN UNION RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY COMPONENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPEAN UNION RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPEAN UNION RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPEAN UNION RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPEAN UNION RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPEAN UNION RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPEAN UNION RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY BLOOD BANKS, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPEAN UNION RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2032 (USD MILLION)
  • TABLE 189. BRICS RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 190. BRICS RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY COMPONENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 191. BRICS RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 192. BRICS RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 193. BRICS RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 194. BRICS RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 195. BRICS RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 196. BRICS RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY BLOOD BANKS, 2018-2032 (USD MILLION)
  • TABLE 197. BRICS RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2032 (USD MILLION)
  • TABLE 198. G7 RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 199. G7 RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY COMPONENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 200. G7 RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 201. G7 RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 202. G7 RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 203. G7 RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 204. G7 RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 205. G7 RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY BLOOD BANKS, 2018-2032 (USD MILLION)
  • TABLE 206. G7 RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2032 (USD MILLION)
  • TABLE 207. NATO RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 208. NATO RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY COMPONENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 209. NATO RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 210. NATO RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 211. NATO RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 212. NATO RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 213. NATO RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 214. NATO RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY BLOOD BANKS, 2018-2032 (USD MILLION)
  • TABLE 215. NATO RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2032 (USD MILLION)
  • TABLE 216. GLOBAL RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 217. UNITED STATES RFID BLOOD MONITORING SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 218. UNITED STATES RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY COMPONENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 219. UNITED STATES RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 220. UNITED STATES RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 221. UNITED STATES RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 222. UNITED STATES RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 223. UNITED STATES RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 224. UNITED STATES RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY BLOOD BANKS, 2018-2032 (USD MILLION)
  • TABLE 225. UNITED STATES RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2032 (USD MILLION)
  • TABLE 226. CHINA RFID BLOOD MONITORING SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 227. CHINA RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY COMPONENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 228. CHINA RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 229. CHINA RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 230. CHINA RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 231. CHINA RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 232. CHINA RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 233. CHINA RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY BLOOD BANKS, 2018-2032 (USD MILLION)
  • TABLE 234. CHINA RFID BLOOD MONITORING SYSTEM MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2032 (USD MILLION)